Summary
Drug companies plan to raise prices on at least 350 medications in the U.S. in 2026, including vaccines and cancer treatments. This follows efforts by the Trump administration to lower medication costs. Some companies, like Pfizer, are leading these price increases, while a few drugs will see price cuts.
Key Facts
- Drugmakers will increase prices on over 350 medications in the U.S. in 2026.
- Price hikes include COVID-19 vaccines, migraine treatments, and cancer drugs.
- Pfizer plans to raise prices for about 80 drugs and vaccines.
- Pfizer's COVID-19 vaccine, Comirnaty, will go up by 15%.
- Some drug prices, like Jardiance for diabetes, will be cut.
- The Trump administration has pushed for lower drug costs, but overall prices will still rise.
- Price increases are mostly around 4%, consistent with the previous year.
